Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activityLing Li, Jin Liu, Zichao Yang et al.|Bioorganic Chemistry|2021Cited by 40
Corrigendum to “Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity” [Bioorgan. Chem. 117 (2021) 105447]Ling Li, Chenglong Xu, Yinrong Wu et al.|Bioorganic Chemistry|2024Cited by 0